Related Experiment Video
Updated: Aug 10, 2025

07:20
Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
Published on: January 28, 2014
36.6K
Global priorities for large-scale biomarker-based prospective cohorts
Rory Collins1, Mary K Balaconis2, Søren Brunak3
1Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Cell Genomics
|February 13, 2023
Summary
Establishing large prospective cohorts with biological samples is key to understanding common health outcomes. Strategic international planning is needed for accessible, deeply characterized cohorts.
Area of Science:
- Population health science
- Genomic epidemiology
- Environmental health research
Background:
- Focuses on strategic approaches for establishing population-based prospective cohorts.
- Aims to collect biological samples from very large participant numbers to identify determinants of common health outcomes.
- Addresses genetic, social, environmental, and ancestral diversity.
Discussion:
- Highlights the need for detailed genetic and assay data generation.
- Emphasizes collecting comprehensive lifestyle and environmental exposure information.
- Discusses follow-up and characterization of incident health outcomes.
Key Insights:
- Overcoming obstacles to data sharing and access is crucial, including capacity building.
- Current approaches to cohort development are often ad hoc.
- International-level strategic planning is necessary.
Outlook:
- Recommends developing a carefully selected set of deeply characterized, large-scale prospective cohorts.
- Advocates for cohorts that are readily accessible to researchers globally.
- Stresses the importance of a coordinated international strategy for future research.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
155
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
155
Genome-wide Association Studies-GWAS
13.8K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.8K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
221
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
221

